Hyperparathyroidism secondary (SHPT) to chronic kidney disease (CKD) is characterizedby elevated serum levels of parathyroid hormone (PTH), hyperplasia of theparathyroid glands, high turnover bone disease and cardiovascular disease1, 2, 3. This evidence concerns the gene PTH and chronic kidney disease.